Sign in
GOSS Stock Price, Chart, Stats & News
Gossamer Bio, Inc.
Save
39.40M
Market cap
–
Current P/E
–
Forward P/E
GOSS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 99.53% |
Operating margin | -352.23% |
Pretax margin | -351.67% |
Net margin | -351.49% |
Effective tax rate | 0.05% |
ROA | -98.91% |
ROE | 264.70% |
D/E | -1.65x |
Interest coverage ratio | -15.54x |
GOSS valuation
P/E | – |
P/S | 1.68x |
P/B | -0.64x |
P/CF | -0.46x |
P/FCF | -0.47x |
P/OCF | -0.46x |
PEG | 0.05x |
EV multiple | 0.52x |
About
Gossamer Bio, Inc. operates as a U. S.-based, clinical-stage biopharmaceutical company. Its primary objective is to discover, acquire, advance, and market novel therapeutic solutions, specifically addressing conditions within immunology, inflammatory diseases, and oncology.
Similar securities
Based on sector and market capitalization
Report issue